title: Minimizing complications in autoimmune blistering diseases.
abstract: Autoimmune blistering diseases (AIBD) often require high-dose corticosteroids and immunosuppressive agents for adequate control. These diseases cause significant morbidity but treatment can also lead to side effects and complications. This article reviews the supportive management of AIBD and the management of corticosteroid-induced side effects. The prevention and management of secondary effects from some of the more commonly used steroid-sparing agents for AIBD are summarized. Clinicians must be familiar with this information to optimally manage patients with AIBD.
authors.affiliation: Meharry Medical College, 1829 Morena Street, Apartment B, Nashville, TN 37208, USA.
authors.forename: Tiffany
authors.initials: T
authors.lastname: Clay
authors.forename: Amit G
authors.initials: AG
authors.lastname: Pandya
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001768:Blister / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy
chemical_list: D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents